Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

This publication has 35 references indexed in Scilit:

• ApoC-III gene polymorphisms and risk of coronary artery disease
  Journal of Lipid Research, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Etiology of the Metabolic Syndrome: Potential Role of Insulin Resistance, Leptin Resistance, and Other Players
  Annals of the New York Academy of Sciences, 1999
• Role of ApoCs in Lipoprotein Metabolism
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children
  Human Genetics, 1996
• Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
  Journal of Clinical Investigation, 1986